Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stevanato Group S.p.A (STVN) EPS (Basic) (2020 - 2026)

Stevanato Group S.p.A (STVN) reported EPS (Basic) of $0.12 for Q1 2026, up 11.3% year-over-year from $0.11 in Q1 2025, and down 40.84% on a QoQ basis from $0.2 in Q4 2025.

Stevanato Group S.p.A (STVN) has 7 years of EPS (Basic) data on file, last reported at $0.12 in Q1 2026.

  • Quarterly EPS (Basic) rose 11.3% year-over-year to $0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.59 (up 17.24% YoY) and the FY2025 annual result came in at $0.59, up 29.2% from the prior year.
  • EPS (Basic) declined to $0.12 in Q1 2026 per STVN's latest filing, from $0.2 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.2 in Q4 2025 and bottomed at $0.08 in Q1 2024.
  • The 5-year median for EPS (Basic) is $0.13 (2022), against an average of $0.14.
  • The widest annual swing landed in 2022, when EPS (Basic) soared 71.0%; it then sank 39.14% in 2024.
  • Tracing STVN's EPS (Basic) over 5 years: stood at $0.18 in 2022, then dropped by 0.4% to $0.18 in 2023, then grew by 5.16% to $0.19 in 2024, then increased by 2.88% to $0.2 in 2025, then tumbled by 40.84% to $0.12 in 2026.
  • Per Business Quant, the three latest STVN EPS (Basic) figures stand at $0.12 (Q1 2026), $0.2 (Q4 2025), and $0.15 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 2.31
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -0.13
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 2.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 1.93
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.07
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.67
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 1.58
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -0.03
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 1.13
10 Stevanato Group S.p.A 5.73 Bn 5.59 Bn 88.04 Mn 0.12

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.12
Dec 31, 2025 0.20
Sep 30, 2025 0.15
Jun 30, 2025 0.12
Mar 31, 2025 0.11
Dec 31, 2024 0.19
Sep 30, 2024 0.12
Jun 30, 2024 0.09
Mar 31, 2024 0.08
Dec 31, 2023 0.18
Sep 30, 2023 0.15
Jun 30, 2023 0.14
Mar 31, 2023 0.12
Dec 31, 2022 0.18
Sep 30, 2022 0.14
Jun 30, 2022 0.13
Mar 31, 2022 0.11
Dec 31, 2021 0.19
Sep 30, 2021 0.08
Jun 30, 2021 0.17
Mar 31, 2021 0.18
Dec 31, 2020 0.17
Sep 30, 2020 0.08
Jun 30, 2020 0.10